Market Overview:
The global NGS market is expected to reach USD 7.5 billion by 2030, registering a CAGR of 10.8% during the forecast period 2018-2030. The growth in this market can be attributed to the increasing demand for Next Generation Sequencing (NGS) services from academic institutes and research centers, hospitals and clinics, pharmaceutical and biotechnology companies, and others across the globe. Additionally, technological advancements in NGS platforms such as NovaSeq, NextSeq, Sequel IIx/IIIx systems are also propelling the growth of this market. However; high cost of sequencing is restraining the growth of this market to some extent. Based on type, the global NGS market is segmented into NovaSeq Systems (including S1 & S2), NextSeq Systems (includingNextSeq 500 &Nextseq 550), Sequel IIx/IIIx systemsand nanopore sequencers). Based on application type; it is segmented into academic institutes & research centers hospitals & clinics Pharmaceuticals Biotech Companies Others).
Product Definition:
NGS is a sequencing technology that allows scientists to read the order of nucleotides in a DNA molecule. This technology is important because it can be used to sequence genomes, which is the complete set of genetic information for an organism.
NovaSeq:
NovaSeq is a new type of sequencing technology that was developed by Illumina, Inc. It is an alternative to MiSeq and HiSeq. NovaSeq can produce higher quality raw data than other technologies due to its faster speed (500 Mhz as opposed to 250 MHz). The technology has been commercialized by the company in 2015 and currently available only in few regions such as Japan, Korea, U.S.
NextSeq:
NextSeq is a next-generation sequencer based on the principle of DNA microarrays. It was developed by Illumina, Inc. for high-throughput sequencing applications and has since been adopted by several other life science companies as well as academic researchers. NextSeq provides improved performance over previous solutions in terms of accuracy, speed, capacity and cost efficiency which has made it one of the most popular platforms for NGS workflows.
Application Insights:
Based on application, the global market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical and biotechnology companies and others. The academic institutes & research centers segment dominated the overall industry in terms of revenue in 2017. This can be attributed to factors such as rising number of government-supported initiatives for supporting genomic research activities at various universities and private institutions across the globe. For instance, according to an article published by NCBI in 2015 titled ¢â‚¬Å“Genomic Research In India: Past Trends And Future Prospects¢â‚¬ it was estimated that around USD 120 million were invested by the Government of India for supporting genomic research activities at various institutes across the country over a period from 2009 to 2013. Such supportive initiatives are fueling growth of this segment globally.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. This can be attributed to the presence of a substantial number of NGS service providers, increased adoption by academic and research institutes, and strong government support for sequencing-based studies. Moreover, increasing investments by pharmaceutical companies are expected to boost the growth further. For instance, in May 2018 FUJIFILM Diosynth Biotechnologies U.S.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to an increase in sequencing demand due mainly expansionary economic conditions coupled with rising healthcare expenditure levels which have led many countries such as China & India & Singapore etc.
Growth Factors:
- Increasing demand for personalized medicine
- Growing application of NGS in life science research
- Rising number of sequencing service providers
- Technological advancements in NGS platforms and applications
- Proliferation of Next-Generation Sequencing data
Scope Of The Report
Report Attributes
Report Details
Report Title
NGS Market Research Report
By Type
NovaSeq, NextSeq, Sequel, Nanopore
By Application
Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
By Companies
Illumina (US), Thermo Fisher Scientific (US), Pacific Biosciences of California (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN(Germany), Macrogen(South Korea), Oxford Nanopore Technologies, Ltd. (UK), Eurofins Scientific (Luxembourg)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
220
Number of Tables & Figures
154
Customization Available
Yes, the report can be customized as per your need.
Global NGS Market Report Segments:
The global NGS market is segmented on the basis of:
Types
NovaSeq, NextSeq, Sequel, Nanopore
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Illumina (US)
- Thermo Fisher Scientific (US)
- Pacific Biosciences of California (US)
- BGI (China)
- PerkinElmer (US)
- Agilent Technologies (US)
- QIAGEN(Germany)
- Macrogen(South Korea)
- Oxford Nanopore Technologies, Ltd. (UK)
- Eurofins Scientific (Luxembourg)
Highlights of The NGS Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- NovaSeq
- NextSeq
- Sequel
- Nanopore
- By Application:
- Academic Institutes & Research Centers
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the NGS Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
NGS stands for Next Generation Sequencing. NGS is a technology that allows scientists to sequence the entire genome of an organism in a single run. This makes it faster and more efficient than traditional sequencing methods, which can take weeks or even months to complete.
Some of the major players in the ngs market are Illumina (US), Thermo Fisher Scientific (US), Pacific Biosciences of California (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN(Germany), Macrogen(South Korea), Oxford Nanopore Technologies, Ltd. (UK), Eurofins Scientific (Luxembourg).
The ngs market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 NGS Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 NGS Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 NGS Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the NGS Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global NGS Market Size & Forecast, 2020-2028 4.5.1 NGS Market Size and Y-o-Y Growth 4.5.2 NGS Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 NovaSeq
5.2.2 NextSeq
5.2.3 Sequel
5.2.4 Nanopore
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Academic Institutes & Research Centers
6.2.2 Hospitals & Clinics
6.2.3 Pharmaceutical & Biotechnology Companies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global NGS Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 NGS Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 NovaSeq
9.6.2 NextSeq
9.6.3 Sequel
9.6.4 Nanopore
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Academic Institutes & Research Centers
9.10.2 Hospitals & Clinics
9.10.3 Pharmaceutical & Biotechnology Companies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 NovaSeq
10.6.2 NextSeq
10.6.3 Sequel
10.6.4 Nanopore
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Academic Institutes & Research Centers
10.10.2 Hospitals & Clinics
10.10.3 Pharmaceutical & Biotechnology Companies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 NovaSeq
11.6.2 NextSeq
11.6.3 Sequel
11.6.4 Nanopore
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Academic Institutes & Research Centers
11.10.2 Hospitals & Clinics
11.10.3 Pharmaceutical & Biotechnology Companies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 NovaSeq
12.6.2 NextSeq
12.6.3 Sequel
12.6.4 Nanopore
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Academic Institutes & Research Centers
12.10.2 Hospitals & Clinics
12.10.3 Pharmaceutical & Biotechnology Companies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 NovaSeq
13.6.2 NextSeq
13.6.3 Sequel
13.6.4 Nanopore
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Academic Institutes & Research Centers
13.10.2 Hospitals & Clinics
13.10.3 Pharmaceutical & Biotechnology Companies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 NGS Market: Competitive Dashboard
14.2 Global NGS Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Illumina (US)
14.3.2 Thermo Fisher Scientific (US)
14.3.3 Pacific Biosciences of California (US)
14.3.4 BGI (China)
14.3.5 PerkinElmer (US)
14.3.6 Agilent Technologies (US)
14.3.7 QIAGEN(Germany)
14.3.8 Macrogen(South Korea)
14.3.9 Oxford Nanopore Technologies, Ltd. (UK)
14.3.10 Eurofins Scientific (Luxembourg)